(Q40391114)

20 September 2017

1 reference

title

Nonseminomatous germ cell tumors of the testis: current concepts and controversies (English)

1 reference

20 September 2017

Sheinfeld J

1

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 July 1994

1 reference

20 September 2017

1 reference

20 September 2017

volume

44

1 reference

20 September 2017

issue

1

1 reference

20 September 2017

page(s)

2-14

1 reference

A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Radiotherapy and testicular neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Prognostic factors in stage I non-seminomatous germ-cell testicular tumors managed by orchiectomy and surveillance: implications for adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Clinical stage I nonseminomatous and mixed germ cell tumors of the testis. A clinicopathologic study of 93 patients on a surveillance protocol after orchiectomy alone

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Orchidectomy alone versus orchidectomy plus radiotherapy in stage I nonseminomatous testicular cancer: a randomized study by the Danish Testicular Carcinoma Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Orchiectomy alone in clinical stage I nonseminomatous testis cancer: a critical appraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Stage I nonseminomatous germ cell testicular tumor: prediction of metastatic potential by primary histopathology

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Prognostic factors in nonseminomatous testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Prognostic factors in clinical stage I non-seminomatous germ-cell tumours of the testis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Orchidectomy alone in stage I nonseminomatous testicular germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Vascular invasion as a prognosticator of metastatic disease in nonseminomatous germ cell tumors of the testis. Importance in "surveillance only" protocols

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

The role of computed tomography in the management of testicular teratoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Are lymphangiograms necessary before placing patients with nonseminomatous testicular tumors on surveillance?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Lymphangiography and computerized tomography in testicular carcinoma: how accurate in early stage disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Serum Alpha-Fetoprotein and Human Chorionic Gonadotropin in Patients with Seminoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

A prospective study of cisplatin-based combination chemotherapy in advanced germ cell malignancy: role of maintenance and long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Prognostic factors for favorable outcome in disseminated germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Prognostic Significance of a Decline in Serum Human Chorionic Gonadotropin Levels After Initial Chemotherapy for Advanced Germ-Cell Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Prognosis for pathologic stage I non-seminomatous germ cell tumors of the testis managed by retroperitoneal lymphadenectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Recurrences in surgical stage I nonseminomatous germ cell tumors of the testis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Cytoreductive Surgery for Metastatic Testis Cancer: Tissue Analysis of Retroperitoneal Masses after Chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

The role of surgery following chemotherapy in stage III germ cell neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Post-chemotherapy surgery in advanced non-seminomatous germ-cell testicular tumours: the significance of histology with particular reference to differentiated (mature) teratoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Adjuvant chemotherapy combination of vinblastine, actinomycin D, bleomycin, and chlorambucil following retroperitoneal lymph node dissection for stage II testis tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

The Extent of Surgery after Chemotherapy for Advanced Germ Cell Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Early resection of residual tumor during cisplatin, vinblastine, bleomycin combination chemotherapy in stage III and bulky stage II nonseminomatous testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Treatment of retroperitoneal residual tumor after PVB chemotherapy of nonseminomatous testicular tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Correlation of computerized tomographic changes and histological findings in 80 patients having radical retroperitoneal lymph node dissection after chemotherapy for testis cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Excision of residual masses after platinum based chemotherapy for non-seminomatous germ cell tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

The importance of prognostic factors in the individual treatment of patients with disseminated germ cell tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experience

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Is postchemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Retroperitoneal Lymphadenectomy for Testicular Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965 to 1989): modifications of technique and impact on ejaculation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Is adjuvant chemotherapy necessary for patients with stage B1 testicular cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Adjuvant chemotherapy in nonseminomatous testicular tumour stage II.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Stage II nonseminomatous germ cell tumors of the testis: an analysis of treatment options in patients with low volume retroperitoneal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Complications of thoracoabdominal retroperitoneal lymph node dissection

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Complications of retroperitoneal lymph node dissection

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Complications of retroperitoneal lymphadenectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Complications of transabdominal retroperitoneal lymphadenectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Complications of therapy for testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Return of Fertility After Treatment for Nonseminomatous Testicular Cancer: Changing Concepts

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Distribution of nodal metastases in nonseminomatous testis cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Distribution of retroperitoneal lymph node metastases in testicular germinal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Ejaculation and fertility after extended retroperitoneal lymph node dissection for testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Clinical stage 1 testicular cancer: the role of modified retroperitoneal lymphadenectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Unilateral retroperitoneal lymph node dissection in patients with non-seminomatous testicular tumor in clinical stage I

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Unilateral lymphadenectomy in intraoperative stage I nonseminomatous germinal testis cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

The treatment of ejaculation disorders after retroperitoneal lymph node dissection

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Orchiectomy Alone for Stage I Testicular Non-Seminoma. A Progress Report on the Royal Marsden Hospital Study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Orchiectomy only for clinical stage I nonseminomatous germ cell testis tumors: comparison with pathologic stage I disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Surveillance alone versus radiotherapy after orchiectomy for clinical stage I nonseminomatous testicular cancer. Danish Testicular Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Testicular Cancer: Risk Factors and the Role of Adjuvant Chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Non-seminomatous testis tumors: a plan of management based in 96 patients to improve survival in all stages by combine therapeutic modalities

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Predictors of recurrence in stage II nonseminomatous testicular cancer after lymphadenectomy: implications for adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Stage II nonseminomatous testicular cancer: a 10-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Adjuvant Chemotherapy in Non-Seminomatous Testis Cancer: “Mini-Vab” Regimen: Long-Term Followup

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Retroperitoneal lymphadenectomy and aggressive chemotherapy in nonbulky clinical stage II nonseminomatous germinal testis tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Adjuvant chemotherapy with VAB-3 of stage II-B testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

VAB-6 combination chemotherapy in resected stage II-B testis cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Retroperitoneal lymph node dissection in clinical stage IIA and IIB nonseminomatous germ cell tumours of the testis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Primary chemotherapy for clinical stage II nonseminomatous germ cell tumors of the testis: a follow-up of 50 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

The role of chemotherapy and surgery in the treatment of retroperitoneal metastases in advanced nonseminomatous testis cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Clinical stage II non-seminomatous germ cell testicular tumours. Results of management by primary chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

VAB-6 Combination Chemotherapy in Disseminated Cancer of the Testis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Chemotherapy of disseminated testicular cancer a random prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Two-drug therapy in patients with metastatic germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP)

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

The prognostic significance of endodermal sinus tumor histology among patients treated for stage III nonseminomatous germ cell tumors of the testes

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Comparison of criteria for assigning germ cell tumor patients to "good risk" and "poor risk" studies

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Five-year survival of patients with disseminated nonseminomatous testicular cancer treated with cisplatin, vinblastine, and bleomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Raynaud's Phenomenon: A Common Toxicity After Combination Chemotherapy for Testicular Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Role of etoposide-based chemotherapy in the treatment of patients with refractory or relapsing germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Carboplatin, etoposide, and bleomycin for patients with poor-risk germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

VP-16 plus ifosfamide plus cisplatin as salvage therapy in refractory germ cell cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocol

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Cytoreductive Surgery for Metastatic Testis Cancer: Considerations of Timing and Extent

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Treatment of Recurrent and Widespread Testicular Tumor by Radical Reductive Surgery and Multiple Sequential Chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Non-seminomatous germ cell testicular tumours: residual masses after chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Post-chemotherapy lymph node histology in radiologically normal patients with metastatic nonseminomatous testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Outcome analysis for patients with persistent nonteratomatous germ cell tumor in postchemotherapy retroperitoneal lymph node dissections

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

The growing teratoma syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Surgery in the management of stage III germinal cell tumors. Observations on the M.D. Anderson Hospital experience, 1971-1979.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Teratoma with malignant transformation in germ cell tumors in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Sarcoma arising in a residual testicular teratoma after cytoreductive chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Evidence of Malignant Features in Histologically Mature Teratoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Late recurrence of mature teratoma in nonseminomatous testicular tumors after PVB chemotherapy and surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Teratoma following cisplatin-based combination chemotherapy for nonseminomatous germ cell tumors: a clinicopathological correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Computerized tomography: how accurate for abdominal staging of testis tumors?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Residual abdominal masses after chemotherapy for nonseminomatous testicular cancer: correlation of CT and histology

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumour Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Distribution of retroperitoneal metastases after chemotherapy in patients with nonseminomatous germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Sequential excision of residual thoracic and retroperitoneal masses after chemotherapy for stage III germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Surgical salvage of chemorefractory germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Surgical resection in patients with nonseminomatous germ cell tumor who fail to normalize serum tumor markers after chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

Isochromosome of the short arm of chromosome 12: clinically useful markers for male germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980002-2

7 January 2021

10.1016/S0090-4295(94)80002-2

Identifiers

DOI

1 reference

release_tnm7vkefdvd63jiu6tvpltrwry

20 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tnm7vkefdvd63jiu6tvpltrwry

24 November 2022

mapped directly with Wikidata item

1 reference